Glabellar Frown Lines (GL)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Glabellar Frown Lines (GL) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 3

NCT04247074

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL,…

United States413 participantsStarted 2020-02-10

Treatment: botulinum toxin neuromodulator, Placebo

CompletedPhase 2

NCT02939326

Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines

To evaluate the safety and efficacy of EB-001 compared to placebo in subjects with glabellar frown lines (GL).

United States42 participantsStarted 2016-12

Treatment: EB-001 injection, Placebo injection